Correlation Between Viridian Therapeutics and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Altamira Therapeutics, you can compare the effects of market volatilities on Viridian Therapeutics and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Altamira Therapeutics.
Diversification Opportunities for Viridian Therapeutics and Altamira Therapeutics
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Viridian and Altamira is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Altamira Therapeutics
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 0.96 times more return on investment than Altamira Therapeutics. However, Viridian Therapeutics is 1.04 times less risky than Altamira Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.19 per unit of risk. If you would invest 1,198 in Viridian Therapeutics on August 27, 2024 and sell it today you would earn a total of 905.00 from holding Viridian Therapeutics or generate 75.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Altamira Therapeutics
Performance |
| Timeline |
| Viridian Therapeutics |
| Altamira Therapeutics |
Viridian Therapeutics and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Altamira Therapeutics
The main advantage of trading using opposite Viridian Therapeutics and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Altamira Therapeutics vs. Eliem Therapeutics | Altamira Therapeutics vs. HCW Biologics | Altamira Therapeutics vs. Scpharmaceuticals | Altamira Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |